Publications – Frailty Prevention (Book Chapters)

  1. Adachi JD, Papaioannou A, Ioannidis G.  Diet in Relation to Osteoporosis.  In Current Perspectives on Nutrition and Health (ed. Carroll KK). McGill-Queen’s University Press, Montreal, pp167-176, 1998.
  2. Adachi JD, Papaioannou A. Hormone Replacement Therapy. In The Osteoporosis Primer. (eds. Henderson JE, Goltzman D). Cambridge University Press, London, UK, pp 277-290, 2000.
  3. Papaioannou A, Ferko NC, Adachi JD. Corticosteroids and the Skeletal System. In Principles of Corticosteroid Therapy. Edward Arnold Ltd., London, UK, pp69-85, 2002.
  4. Papaioannou A. Pharmacological Issues in the Very Old.  In Aging Issues for Cardiologists. The Treatment of Heart Disease, Chapter 4;69-82, 2003.
  5. Kherani RB, McIlhagger R, Papaioannou A, Adachi JD.  Guidelines in US, UK and Canada.  In Glucocorticoid-Induced Osteoporosis: A Practical Manual, pp90-116.  Life Science Publishing, Osteoporosis Japan, ISBN4-89775-185-3 C3047 Y1800E, 2004.
  6. Papaioannou A, Cranney A, Adachi JD.  Corticosteroid-Induced Osteoporosis: A Comprehensive Review.   In Principles of Gender-Specific Medicine. Volume 2(91) pp 981-994, 2004.
  7. Adachi JD, Papaioannou A,.  How to Prevent Corticosteroid-Induced Osteoporosis. In Lupus-The Disease with a Thousand Faces (eds Senécal, Bernatsky S, Fortin P), Key Porter Books, 2004.
  8. Adachi JD, Papaioannou A.  Drugs That Alter Bone Metabolism for the Treatment of Osteoporosis.  In Kalant H, Grant D, Mitchell J (eds) Principles of Medical Pharmacology (pp878-889).  Elsvier Canada. Toronto, Ontario, 2005.
  9. Adachi JD, Papaioannou A, Giangregorio LM.  Drug-Induced Bone Loss.  In Bone Disease in Rheumatology. Chapter 13 pp120-122, 2005.
  10. Adachi JD, Papaioannou A. In Whom and How to Prevent Glucocorticoid-induced Osteoporosis. Best Practice & Research Clinical Rheumatology. Volume 19(6) pp1039-1064, 2005.
  11. Giangregorio LM, Papaioannou A, Adachi JD. Osteomalacia.  In Schulz R., Noelker L., Rockwood K., Sprott R. (eds.).  The Encyclopedia of Aging, Fourth Edition (pp. 881-882).  New York: Springer Publishing Company, 2006.
  12. Giangregorio LM, Papaioannou A, Adachi JD. Osteoporosis.  In Schulz R., Noelker L., Rockwood K., Sprott R. (eds.), The Encyclopedia of Aging, Fourth Edition, (pp. 883-885).  New York:  Springer Publishing Company, 2006.
  13. Adachi JD, Papaioannou A.  Strontium and parathyroid hormone.  In Osteoporosis 2.  The year in osteoporosis. eds Akesson K., Adachi JD, Woolf AD. pp281-295 Clinical Publishing.  Mill Street, Oxford 0X2 0JX, UK. ISBN 1904392 62 8, 2006.
  14. Adachi JD, Papaioannou A.  Drugs that alter bone metabolism for the treatment of osteoporosis.  In Kalant H, Grant D, Mitchell J (eds). Principals of Medical Pharmacology (pp878 – 889). Elsevier Canada. Toronto, Ontario, 2006.
  15. Giangregorio L, Papaioannou A.  Osteoporosis and metabolic bone disease.  In Y. Nakasato and RL Yung (eds.), Geriatric Rheumatology: A Comprehensive Approach, DOI 10.1007/978-1-4419-5792-4-25, © Springer Science+Business Media, LLC 2011 (pp241-250).
  16. Papaioannou A, Agarwal A, Karampatos S.  The Impact of Regulatory and Scientific Organizations’ Recommendations on Clinical Decision-Making.    In The Duration and Safety of Osteoporosis Treatment, Anabolic and Antiresorptive Therapy, SpringerLink – 2016, Editors Stuart Silverman, Bo Abrahamsen (pp 295-308).